Today the NIH ended their moratorium on GOF research which was enacted in 2014. The moratorium was put in place partially in response to two flu research projects which caused concerns in the international research community (or more specifically the political and public health communities) in 2012. In coordination to the lifting of the moratorium the DHHS posted new guidelines to assist researchers in identifying the type of research and process for approval that these GOF research activities may fall under. The lifting of this ban will permit research which many find critical for understanding the mechanisms of parthenogenesis for viruses such as MERS and SARS. This research may lead to novel and effective vaccines or therapeutics which can save lives, especially if another global outbreak of SARS occurs. While these research activities may lead to unforeseen changes in the studied pathogen, by permitting researchers to do this work the NIH is ensuring any such GOF occurs in the proper biosafety environment while also helping to promote a better understanding of these dangerous pathogen.